Becton, Dickinson and Company BDX Enterprise value

Enterprise value at other companies

AbbottABT

$185.56B-24.8%

Baxter InternationalBAX

$6.88B-55.6%

Bio-Rad LaboratoriesBIO

$8B+4.2%

TFX

TeleflexTFX

$7.74B-2.0%

Thermo Fisher ScientificTMO

$225.77B+21.7%

West Pharmaceutical ServicesWST

$25.24B+59.8%

FAQ

What is Becton, Dickinson and Company's enterprise value?

Becton, Dickinson and Company (BDX) reported enterprise value of $58.42B in Q1 2026.

How has Becton, Dickinson and Company's enterprise value changed year-over-year?

Becton, Dickinson and Company's enterprise value decreased by 29.4% year-over-year, from $82.76B to $58.42B.

What is the long-term trend for Becton, Dickinson and Company's enterprise value?

Over 4 years (2021 to 2025), Becton, Dickinson and Company's enterprise value has grown at a -4.3% compound annual growth rate (CAGR), from $84.91B to $71.33B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.